News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genesis Bioventures (GBIW) Announces Letter of Intent for Sales and Distribution of Mad Cow Test Product in China


7/3/2007 12:50:54 PM

LOS ANGELES--(BUSINESS WIRE)--Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that BioBDC, the Company’s exclusive agent for sales and distribution of Prion Developmental Laboratories’ (PDL) Rapid BSE assay for Mad Cow testing for the Pacific Rim, received a Letter of Intent from Wantai Biological Pharmacy Enterprise Co., Ltd. in Beijing, to sell and distribute the Rapid BSE test kits throughout China.

Read at BioSpace.com

comments powered by Disqus
   
Mad Cow

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES